• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

儿童致残性全硬化性硬斑病

Disabling pansclerotic morphoea of childhood.

作者信息

Jamalpur Indirakshi, Mogili Harikrishna Reddy, Koratala Abhilash

机构信息

Department of Dermatology, Kurnool Medical College, Kurnool, Andhra Pradesh, India.

Department of Medicine, Sri Venkateswara Institute of Medical Sciences, Tirupati, Andhra Pradesh, India.

出版信息

BMJ Case Rep. 2018 Feb 17;2018:bcr-2017-222132. doi: 10.1136/bcr-2017-222132.

DOI:10.1136/bcr-2017-222132
PMID:29455178
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5836610/
Abstract

Disabling pansclerotic morphoea (DPM) of childhood is a severe and often fatal variant of deep morphoea. It usually starts in childhood and rarely seen in adults. The course of the disease is progressive with lifelong morbidity in the form of joint contractures and immobility. The causes of mortality include complications such as sepsis, gangrene and cardiopulmonary involvement. Herein, we discuss the case of a 15-year-old girl with limb deformity and finger contractures, that is, bone involvement. The diagnosis of DPM of childhood was fortuitously made after the correction of limb deformity, when the patient was seen in the dermatology department for evaluation of skin discolouration on the thighs.

摘要

儿童致残性全硬化性硬斑病(DPM)是深部硬斑病的一种严重且常致命的变体。它通常始于儿童期,在成人中很少见。疾病进程呈进行性,会导致关节挛缩和活动障碍等终身残疾。死亡原因包括败血症、坏疽和心肺受累等并发症。在此,我们讨论一名15岁女孩的病例,她有肢体畸形和手指挛缩,即骨骼受累。该患儿在矫正肢体畸形后偶然被诊断为儿童DPM,当时她因大腿皮肤变色到皮肤科就诊。

相似文献

1
Disabling pansclerotic morphoea of childhood.儿童致残性全硬化性硬斑病
BMJ Case Rep. 2018 Feb 17;2018:bcr-2017-222132. doi: 10.1136/bcr-2017-222132.
2
Disabling pansclerotic morphea of childhood--unusual case and management challenges.儿童致残性全硬化性硬斑病——罕见病例及管理挑战
J Med Life. 2008 Jul-Sep;1(3):348-54.
3
[Severe course of a mutilating pansclerotic circumscribed scleroderma in childhood. Clinical aspects and therapy].[儿童致残性泛硬化性局限性硬皮病的严重病程。临床特点及治疗]
Hautarzt. 1999 Feb;50(2):131-5. doi: 10.1007/s001050050877.
4
Disabling pansclerotic morphea of childhood with extracutaneous manifestations.伴有皮肤外表现的儿童致残性全硬化性硬斑病
Indian J Dermatol. 2013 Mar;58(2):159. doi: 10.4103/0019-5154.108079.
5
Challenges in the diagnosis and treatment of disabling pansclerotic morphea of childhood: case-based review.儿童致残性泛发性硬斑病的诊断和治疗挑战:基于病例的回顾。
Rheumatol Int. 2019 May;39(5):933-941. doi: 10.1007/s00296-019-04269-w. Epub 2019 Mar 5.
6
[Incapacitating pansclerotic morphea in childhood].[儿童致残性全硬化性硬斑病]
Med Cutan Ibero Lat Am. 1981;9(5):377-82.
7
Efficacy of bosentan in treatment of unresponsive cutaneous ulceration in disabling pansclerotic morphea in children.波生坦治疗儿童致残性全硬化性硬斑病中难治性皮肤溃疡的疗效。
J Rheumatol. 2006 Dec;33(12):2538-40.
8
Disabling pansclerotic morphea: clinical presentation in two adults.致残性全硬化性硬斑病:两名成人的临床表现
J Am Acad Dermatol. 2005 Aug;53(2 Suppl 1):S115-9. doi: 10.1016/j.jaad.2004.10.881.
9
Disabling pansclerotic morphea of childhood poses a high risk of chronic ulceration of the skin and squamous cell carcinoma.儿童致残性全硬化性硬斑病存在皮肤慢性溃疡和鳞状细胞癌的高风险。
Int J Low Extrem Wounds. 2007 Dec;6(4):291-8. doi: 10.1177/1534734607308731.
10
Disabling pansclerotic morphea of childhood and hypogammaglobulinemia: a curious association.儿童致残性全硬化性硬斑病与低丙种球蛋白血症:一种奇特的关联。
Rheumatol Int. 2002 Jan;21(4):158-60. doi: 10.1007/s00296-001-0150-2.

引用本文的文献

1
Morphea: The 2023 update.硬斑病:2023年更新版
Front Med (Lausanne). 2023 Feb 13;10:1108623. doi: 10.3389/fmed.2023.1108623. eCollection 2023.
2
Challenges in the diagnosis and treatment of disabling pansclerotic morphea of childhood: case-based review.儿童致残性泛发性硬斑病的诊断和治疗挑战:基于病例的回顾。
Rheumatol Int. 2019 May;39(5):933-941. doi: 10.1007/s00296-019-04269-w. Epub 2019 Mar 5.

本文引用的文献

1
Pediatric generalized morphea that developed at a BCG vaccination site.在卡介苗接种部位发生的小儿泛发性硬斑病。
Actas Dermosifiliogr. 2015 Mar;106(2):150-2. doi: 10.1016/j.ad.2014.06.012. Epub 2014 Sep 26.
2
Disabling pansclerotic morphea of childhood with extracutaneous manifestations.伴有皮肤外表现的儿童致残性全硬化性硬斑病
Indian J Dermatol. 2013 Mar;58(2):159. doi: 10.4103/0019-5154.108079.
3
Morphea in adults and children cohort II: patients with morphea experience delay in diagnosis and large variation in treatment.成人和儿童硬斑病队列研究 II:硬斑病患者的诊断存在延迟,治疗存在较大差异。
J Am Acad Dermatol. 2012 Nov;67(5):881-9. doi: 10.1016/j.jaad.2012.01.011. Epub 2012 Feb 29.
4
Disabling pansclerotic morphea of childhood--unusual case and management challenges.儿童致残性全硬化性硬斑病——罕见病例及管理挑战
J Med Life. 2008 Jul-Sep;1(3):348-54.
5
Efficacy of bosentan in treatment of unresponsive cutaneous ulceration in disabling pansclerotic morphea in children.波生坦治疗儿童致残性全硬化性硬斑病中难治性皮肤溃疡的疗效。
J Rheumatol. 2006 Dec;33(12):2538-40.
6
Phototherapy: a promising treatment option for skin sclerosis in scleroderma?光疗:系统性硬化症皮肤硬化的一种有前景的治疗选择?
Rheumatology (Oxford). 2006 Oct;45 Suppl 3:iii52-iii54. doi: 10.1093/rheumatology/kel293.
7
Localized scleroderma in childhood is not just a skin disease.儿童局限性硬皮病不仅仅是一种皮肤病。
Arthritis Rheum. 2005 Sep;52(9):2873-81. doi: 10.1002/art.21264.
8
Disabling pansclerotic morphea: clinical presentation in two adults.致残性全硬化性硬斑病:两名成人的临床表现
J Am Acad Dermatol. 2005 Aug;53(2 Suppl 1):S115-9. doi: 10.1016/j.jaad.2004.10.881.
9
Severe ankle deformity secondary to pansclerotic morphea in a 9-year-old girl: correction involving arthrodesis and free flap coverage.一名9岁女孩因泛硬化性硬斑病继发严重踝关节畸形:采用关节融合术及游离皮瓣覆盖进行矫正。
Pediatr Dermatol. 2002 Nov-Dec;19(6):560-3. doi: 10.1046/j.1525-1470.2002.00235.x.
10
Linear scleroderma. Clinical spectrum, prognosis, and laboratory abnormalities.线状硬皮病。临床谱、预后及实验室异常情况。
Ann Intern Med. 1986 Jun;104(6):849-57. doi: 10.7326/0003-4819-104-6-849.